OptimizeRx Corp (OPRX) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
OptimizeRx Corp quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • OptimizeRx Corp Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$71.2 M, a 34% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$71.2 M -$18.1 M -34% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$64.3 M -$17.6 M -37.6% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$60.1 M -$13.8 M -29.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$57.3 M -$14.4 M -33.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$53.1 M -$14.1 M -36.1% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$46.7 M -$11.4 M -32.4% Dec 31, 2022 10-K 2024-04-15
Q3 2022 -$46.4 M -$10.5 M -29.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$42.9 M -$6.98 M -19.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$39 M -$2.75 M -7.57% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$35.3 M +$378 K +1.06% Dec 31, 2021 10-K 2023-03-10
Q3 2021 -$35.9 M +$1.11 M +3.01% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 -$35.9 M +$789 K +2.15% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 -$36.3 M -$641 K -1.8% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$35.6 M -$2.21 M -6.6% Dec 31, 2020 10-K/A 2023-03-10
Q3 2020 -$37 M -$5.55 M -17.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$36.7 M -$6.84 M -22.9% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$35.6 M -$5.35 M -17.7% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 -$33.4 M -$3.15 M -10.4% Dec 31, 2019 10-K 2021-03-08
Q3 2019 -$31.4 M -$1.27 M -4.21% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 -$29.9 M +$545 K +1.79% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$30.3 M +$419 K +1.36% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 -$30.3 M +$84.3 K +0.28% Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$30.2 M -$42.8 K -0.14% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 -$30.4 M -$911 K -3.09% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 -$30.7 M -$1.55 M -5.33% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 -$30.4 M -$2.1 M -7.45% Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$30.1 M -$2.22 M -7.95% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 -$29.5 M -$1.84 M -6.65% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 -$29.1 M -$2.07 M -7.65% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 -$28.3 M -$1.54 M -5.76% Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$27.9 M -$1.6 M -6.09% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 -$27.7 M -$1.27 M -4.81% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 -$27.1 M -$836 K -3.19% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 -$26.7 M -$595 K -2.28% Dec 31, 2015 10-K 2017-03-08
Q3 2015 -$26.3 M +$50.2 K +0.19% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 -$26.4 M -$332 K -1.28% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 -$26.2 M -$374 K -1.45% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 -$26.1 M -$1.03 M -4.09% Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$26.4 M -$1.21 M -4.83% Sep 30, 2014 10-K/A 2015-09-16
Q2 2014 -$26.1 M -$1.57 M -6.41% Jun 30, 2014 10-K/A 2015-09-16
Q1 2014 -$25.9 M -$1.02 M -4.09% Mar 31, 2014 10-K/A 2015-09-16
Q4 2013 -$25.1 M -$267 K -1.08% Dec 31, 2013 10-K/A 2015-09-16
Q3 2013 -$25.1 M -$281 K -1.13% Sep 30, 2013 10-K/A 2015-09-16
Q2 2013 -$24.5 M +$262 K +1.06% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 -$24.8 M -$168 K -0.68% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 -$24.8 M -$455 K -1.87% Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$24.9 M -$987 K -4.13% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 -$24.8 M -$2.1 M -9.27% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 -$24.7 M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 -$24.4 M -$2.62 M -12% Dec 31, 2011 10-K 2013-03-12
Q3 2011 -$23.9 M Sep 30, 2011 10-Q/A 2011-11-23
Q2 2011 -$22.7 M Jun 30, 2011 10-Q 2011-08-17
Q4 2010 -$21.8 M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.